Literature DB >> 22930290

A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience.

L Waters1, B Patterson, A Scourfield, A Hughes, S de Silva, B Gazzard, S Barton, D Asboe, A Pozniak, M Boffito.   

Abstract

The HIV-infected population is ageing. Issues including polypharmacy and co-morbidities led us to develop a dedicated clinic for HIV-infected individuals over 50. We describe our service evaluation after two years. The over 50 clinic commenced in January 2009. The team comprises a registrar, consultant, nurse practitioner and is supported by a pharmacist and mental health services. Patients undergo a full medication and drug interactions review, neurocognitive assessment, adherence self-assessment and investigations including therapeutic drug monitoring (TDM), coronary artery calcium scores (CACS) and bone mineral density. Over two years of activity, 150 patients attended the service. Median (range) age was 58 (50-88), all were on combined antiretroviral therapy and 38% (57/150) were on ≥3 non-HIV drugs. CACS was high (>90th centile) in 14%. Thirty-eight percent had osteopaenia and 18% had osteoporosis requiring treatment. Thirteen out of 125 men had an increased prostate specific antigen, four were diagnosed with prostate cancer. Drug interaction, TDM and neurocognitive assessments were useful for several patients. Asymptomatic patients over 50 in long-term follow-up had new pathologies detected through targeted screening. The clinic has improved general practitioner (GP) liaison and facilitated closer working relationships with other specialties. Patients have reacted positively to the clinic, particularly as many do not routinely access their GP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930290     DOI: 10.1258/ijsa.2012.011412

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  13 in total

1.  The prevalence of comorbidities among people living with HIV in Brent: a diverse London Borough.

Authors:  Ava Lorenc; Piriyankan Ananthavarathan; James Lorigan; Mohamade Jowata; Gary Brook; Ricky Banarsee
Journal:  London J Prim Care (Abingdon)       Date:  2014

Review 2.  Management of human immunodeficiency virus infection in advanced age.

Authors:  Meredith Greene; Amy C Justice; Harry W Lampiris; Victor Valcour
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

Review 3.  Progress and challenges in the use of latent HIV-1 reactivating agents.

Authors:  Hong-tao Shang; Ji-wei Ding; Shu-ying Yu; Tao Wu; Qiu-li Zhang; Fu-jun Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

Review 4.  Cardiovascular disease risk in an aging HIV population: not just a question of biology.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

Review 5.  A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.

Authors:  Lewis John Haddow; Sian Floyd; Andrew Copas; Richard John Cary Gilson
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 6.  The next therapeutic challenge in HIV: polypharmacy.

Authors:  E Jennifer Edelman; Kirsha S Gordon; Janis Glover; Ian R McNicholl; David A Fiellin; Amy C Justice
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923

7.  Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism.

Authors:  Anne K Monroe; Adrian S Dobs; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Todd T Brown
Journal:  AIDS Res Ther       Date:  2014-01-22       Impact factor: 2.250

8.  Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.

Authors:  Sandra W Cardoso; Paula M Luz; Luciane Velasque; Thiago S Torres; Isabel C Tavares; Sayonara R Ribeiro; Ronaldo I Moreira; Valdilea G Veloso; Richard D Moore; Beatriz Grinsztejn
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

9.  Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK.

Authors:  Charlotte-Eve S Short; Simon G Shaw; Martin J Fisher; Karen Walker-Bone; Yvonne C Gilleece
Journal:  Int J STD AIDS       Date:  2013-07-19       Impact factor: 1.359

Review 10.  Polypharmacy in the HIV-infected older adult population.

Authors:  Lauren J Gleason; Amneris E Luque; Krupa Shah
Journal:  Clin Interv Aging       Date:  2013-06-21       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.